BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19225154)

  • 1. The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion.
    Crapeau M; Marchal C; Cullin C; Maillet L
    Mol Biol Cell; 2009 Apr; 20(8):2286-96. PubMed ID: 19225154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.
    Edskes HK; Gray VT; Wickner RB
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1498-503. PubMed ID: 9990052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.
    Ripaud L; Maillet L; Cullin C
    EMBO J; 2003 Oct; 22(19):5251-9. PubMed ID: 14517262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-forming ability of Ure2 of yeasts is not evolutionarily conserved.
    Edskes HK; Engel A; McCann LM; Brachmann A; Tsai HF; Wickner RB
    Genetics; 2011 May; 188(1):81-90. PubMed ID: 21368275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of distinct [URE3] yeast prion strains.
    Schlumpberger M; Prusiner SB; Herskowitz I
    Mol Cell Biol; 2001 Oct; 21(20):7035-46. PubMed ID: 11564886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.
    Edskes HK; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16384-91. PubMed ID: 12177423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae.
    Speransky VV; Taylor KL; Edskes HK; Wickner RB; Steven AC
    J Cell Biol; 2001 Jun; 153(6):1327-36. PubMed ID: 11402074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prion.
    Immel F; Jiang Y; Wang YQ; Marchal C; Maillet L; Perrett S; Cullin C
    J Biol Chem; 2007 Mar; 282(11):7912-20. PubMed ID: 17234629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The [URE3] prion is not conserved among Saccharomyces species.
    Talarek N; Maillet L; Cullin C; Aigle M
    Genetics; 2005 Sep; 171(1):23-34. PubMed ID: 15956663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein-only theory and the yeast Saccharomyces cerevisiae: the prions and the propagons.
    Fernandez-Bellot E; Cullin C
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1857-78. PubMed ID: 11766884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion generation in vitro: amyloid of Ure2p is infectious.
    Brachmann A; Baxa U; Wickner RB
    EMBO J; 2005 Sep; 24(17):3082-92. PubMed ID: 16096644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.
    Wickner RB
    Science; 1994 Apr; 264(5158):566-9. PubMed ID: 7909170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC; Wickner RB
    Science; 1995 Oct; 270(5233):93-5. PubMed ID: 7569955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promiscuous prion: efficient induction of [URE3] prion formation by heterologous prion domains.
    Ross CD; McCarty BR; Hamilton M; Ben-Hur A; Ross ED
    Genetics; 2009 Nov; 183(3):929-40. PubMed ID: 19752212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion variants and species barriers among Saccharomyces Ure2 proteins.
    Edskes HK; McCann LM; Hebert AM; Wickner RB
    Genetics; 2009 Mar; 181(3):1159-67. PubMed ID: 19124570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation.
    Masison DC; Maddelein ML; Wickner RB
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12503-8. PubMed ID: 9356479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The [URE3] phenotype: evidence for a soluble prion in yeast.
    Fernandez-Bellot E; Guillemet E; Ness F; Baudin-Baillieu A; Ripaud L; Tuite M; Cullin C
    EMBO Rep; 2002 Jan; 3(1):76-81. PubMed ID: 11751580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal initiation drives the synthesis of Ure2 protein lacking the prion domain and affects [URE3] propagation in yeast cells.
    Komar AA; Lesnik T; Cullin C; Merrick WC; Trachsel H; Altmann M
    EMBO J; 2003 Mar; 22(5):1199-209. PubMed ID: 12606584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro.
    Ripaud L; Maillet L; Immel-Torterotot F; Durand F; Cullin C
    J Biol Chem; 2004 Dec; 279(49):50962-8. PubMed ID: 15456789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.